 | • レポートコード：MRC2-11QY05384 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はドーパミン剤のグローバル市場について調査・分析したレポートです。種類別（経口、注射可能）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ドーパミン剤の競争状況、市場シェア ・世界のドーパミン剤市場：種類別市場規模 2015年-2020年（経口、注射可能） ・世界のドーパミン剤市場：種類別市場規模予測 2021年-2026年（経口、注射可能） ・世界のドーパミン剤市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のドーパミン剤市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のドーパミン剤市場分析：米国、カナダ ・ヨーロッパのドーパミン剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのドーパミン剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のドーパミン剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのドーパミン剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Glaxosmithkline、Actavis、Eli Lilly、Sun Pharmaceutical、Novartis、Merck、Cardinal Health、Pfizer、Teva、Abbott ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Dopamine Agents Market
The global Dopamine Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Dopamine Agents Scope and Market Size
Dopamine Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dopamine Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dopamine Agents market is segmented into
Oral
Injectable
Segment by Application, the Dopamine Agents market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
The Dopamine Agents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dopamine Agents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dopamine Agents Market Share Analysis
Dopamine Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dopamine Agents business, the date to enter into the Dopamine Agents market, Dopamine Agents product introduction, recent developments, etc.
The major vendors covered:
Glaxosmithkline
Actavis
Eli Lilly
Sun Pharmaceutical
Novartis
Merck
Cardinal Health
Pfizer
Teva
Abbott
1 Study Coverage
1.1 Dopamine Agents Product Introduction
1.2 Market Segments
1.3 Key Dopamine Agents Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dopamine Agents Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injectable
1.5 Market by Application
1.5.1 Global Dopamine Agents Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dopamine Agents Market Size, Estimates and Forecasts
2.1.1 Global Dopamine Agents Revenue 2015-2026
2.1.2 Global Dopamine Agents Sales 2015-2026
2.2 Global Dopamine Agents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dopamine Agents Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dopamine Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dopamine Agents Competitor Landscape by Players
3.1 Dopamine Agents Sales by Manufacturers
3.1.1 Dopamine Agents Sales by Manufacturers (2015-2020)
3.1.2 Dopamine Agents Sales Market Share by Manufacturers (2015-2020)
3.2 Dopamine Agents Revenue by Manufacturers
3.2.1 Dopamine Agents Revenue by Manufacturers (2015-2020)
3.2.2 Dopamine Agents Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dopamine Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dopamine Agents Revenue in 2019
3.2.5 Global Dopamine Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dopamine Agents Price by Manufacturers
3.4 Dopamine Agents Manufacturing Base Distribution, Product Types
3.4.1 Dopamine Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dopamine Agents Product Type
3.4.3 Date of International Manufacturers Enter into Dopamine Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dopamine Agents Market Size by Type (2015-2020)
4.1.1 Global Dopamine Agents Sales by Type (2015-2020)
4.1.2 Global Dopamine Agents Revenue by Type (2015-2020)
4.1.3 Dopamine Agents Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dopamine Agents Market Size Forecast by Type (2021-2026)
4.2.1 Global Dopamine Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Dopamine Agents Revenue Forecast by Type (2021-2026)
4.2.3 Dopamine Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dopamine Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dopamine Agents Market Size by Application (2015-2020)
5.1.1 Global Dopamine Agents Sales by Application (2015-2020)
5.1.2 Global Dopamine Agents Revenue by Application (2015-2020)
5.1.3 Dopamine Agents Price by Application (2015-2020)
5.2 Dopamine Agents Market Size Forecast by Application (2021-2026)
5.2.1 Global Dopamine Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Dopamine Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Dopamine Agents Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dopamine Agents by Country
6.1.1 North America Dopamine Agents Sales by Country
6.1.2 North America Dopamine Agents Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dopamine Agents Market Facts & Figures by Type
6.3 North America Dopamine Agents Market Facts & Figures by Application
7 Europe
7.1 Europe Dopamine Agents by Country
7.1.1 Europe Dopamine Agents Sales by Country
7.1.2 Europe Dopamine Agents Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dopamine Agents Market Facts & Figures by Type
7.3 Europe Dopamine Agents Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dopamine Agents by Region
8.1.1 Asia Pacific Dopamine Agents Sales by Region
8.1.2 Asia Pacific Dopamine Agents Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dopamine Agents Market Facts & Figures by Type
8.3 Asia Pacific Dopamine Agents Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dopamine Agents by Country
9.1.1 Latin America Dopamine Agents Sales by Country
9.1.2 Latin America Dopamine Agents Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dopamine Agents Market Facts & Figures by Type
9.3 Central & South America Dopamine Agents Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dopamine Agents by Country
10.1.1 Middle East and Africa Dopamine Agents Sales by Country
10.1.2 Middle East and Africa Dopamine Agents Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Dopamine Agents Market Facts & Figures by Type
10.3 Middle East and Africa Dopamine Agents Market Facts & Figures by Application
11 Company Profiles
11.1 Glaxosmithkline
11.1.1 Glaxosmithkline Corporation Information
11.1.2 Glaxosmithkline Description and Business Overview
11.1.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Glaxosmithkline Dopamine Agents Products Offered
11.1.5 Glaxosmithkline Related Developments
11.2 Actavis
11.2.1 Actavis Corporation Information
11.2.2 Actavis Description and Business Overview
11.2.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Actavis Dopamine Agents Products Offered
11.2.5 Actavis Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Dopamine Agents Products Offered
11.3.5 Eli Lilly Related Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Description and Business Overview
11.4.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sun Pharmaceutical Dopamine Agents Products Offered
11.4.5 Sun Pharmaceutical Related Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description and Business Overview
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Dopamine Agents Products Offered
11.5.5 Novartis Related Developments
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Description and Business Overview
11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Dopamine Agents Products Offered
11.6.5 Merck Related Developments
11.7 Cardinal Health
11.7.1 Cardinal Health Corporation Information
11.7.2 Cardinal Health Description and Business Overview
11.7.3 Cardinal Health Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Cardinal Health Dopamine Agents Products Offered
11.7.5 Cardinal Health Related Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description and Business Overview
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Dopamine Agents Products Offered
11.8.5 Pfizer Related Developments
11.9 Teva
11.9.1 Teva Corporation Information
11.9.2 Teva Description and Business Overview
11.9.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Teva Dopamine Agents Products Offered
11.9.5 Teva Related Developments
11.10 Abbott
11.10.1 Abbott Corporation Information
11.10.2 Abbott Description and Business Overview
11.10.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Abbott Dopamine Agents Products Offered
11.10.5 Abbott Related Developments
11.1 Glaxosmithkline
11.1.1 Glaxosmithkline Corporation Information
11.1.2 Glaxosmithkline Description and Business Overview
11.1.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Glaxosmithkline Dopamine Agents Products Offered
11.1.5 Glaxosmithkline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dopamine Agents Market Estimates and Projections by Region
12.1.1 Global Dopamine Agents Sales Forecast by Regions 2021-2026
12.1.2 Global Dopamine Agents Revenue Forecast by Regions 2021-2026
12.2 North America Dopamine Agents Market Size Forecast (2021-2026)
12.2.1 North America: Dopamine Agents Sales Forecast (2021-2026)
12.2.2 North America: Dopamine Agents Revenue Forecast (2021-2026)
12.2.3 North America: Dopamine Agents Market Size Forecast by Country (2021-2026)
12.3 Europe Dopamine Agents Market Size Forecast (2021-2026)
12.3.1 Europe: Dopamine Agents Sales Forecast (2021-2026)
12.3.2 Europe: Dopamine Agents Revenue Forecast (2021-2026)
12.3.3 Europe: Dopamine Agents Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dopamine Agents Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dopamine Agents Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dopamine Agents Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dopamine Agents Market Size Forecast by Region (2021-2026)
12.5 Latin America Dopamine Agents Market Size Forecast (2021-2026)
12.5.1 Latin America: Dopamine Agents Sales Forecast (2021-2026)
12.5.2 Latin America: Dopamine Agents Revenue Forecast (2021-2026)
12.5.3 Latin America: Dopamine Agents Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dopamine Agents Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dopamine Agents Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dopamine Agents Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dopamine Agents Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dopamine Agents Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dopamine Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Dopamine Agents Market Segments
Table 2. Ranking of Global Top Dopamine Agents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dopamine Agents Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injectable
Table 6. Global Dopamine Agents Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Dopamine Agents Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Dopamine Agents Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Dopamine Agents Sales Market Share by Regions (2015-2020)
Table 10. Global Dopamine Agents Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Dopamine Agents Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Dopamine Agents Sales Share by Manufacturers (2015-2020)
Table 13. Global Dopamine Agents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Dopamine Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dopamine Agents as of 2019)
Table 15. Dopamine Agents Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Dopamine Agents Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Dopamine Agents Price (2015-2020) (US$/Ton)
Table 18. Dopamine Agents Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Dopamine Agents Product Type
Table 20. Date of International Manufacturers Enter into Dopamine Agents Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Dopamine Agents Sales by Type (2015-2020) (Kiloton)
Table 23. Global Dopamine Agents Sales Share by Type (2015-2020)
Table 24. Global Dopamine Agents Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Dopamine Agents Revenue Share by Type (2015-2020)
Table 26. Dopamine Agents Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Dopamine Agents Sales by Application (2015-2020) (Kiloton)
Table 28. Global Dopamine Agents Sales Share by Application (2015-2020)
Table 29. North America Dopamine Agents Sales by Country (2015-2020) (Kiloton)
Table 30. North America Dopamine Agents Sales Market Share by Country (2015-2020)
Table 31. North America Dopamine Agents Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Dopamine Agents Revenue Market Share by Country (2015-2020)
Table 33. North America Dopamine Agents Sales by Type (2015-2020) (Kiloton)
Table 34. North America Dopamine Agents Sales Market Share by Type (2015-2020)
Table 35. North America Dopamine Agents Sales by Application (2015-2020) (Kiloton)
Table 36. North America Dopamine Agents Sales Market Share by Application (2015-2020)
Table 37. Europe Dopamine Agents Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Dopamine Agents Sales Market Share by Country (2015-2020)
Table 39. Europe Dopamine Agents Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Dopamine Agents Revenue Market Share by Country (2015-2020)
Table 41. Europe Dopamine Agents Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Dopamine Agents Sales Market Share by Type (2015-2020)
Table 43. Europe Dopamine Agents Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Dopamine Agents Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Dopamine Agents Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Dopamine Agents Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Dopamine Agents Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Dopamine Agents Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Dopamine Agents Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Dopamine Agents Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Dopamine Agents Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Dopamine Agents Sales Market Share by Application (2015-2020)
Table 53. Latin America Dopamine Agents Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Dopamine Agents Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Dopamine Agents Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Dopamine Agents Revenue Market Share by Country (2015-2020)
Table 57. Latin America Dopamine Agents Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Dopamine Agents Sales Market Share by Type (2015-2020)
Table 59. Latin America Dopamine Agents Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Dopamine Agents Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Dopamine Agents Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Dopamine Agents Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Dopamine Agents Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Dopamine Agents Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Dopamine Agents Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Dopamine Agents Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Dopamine Agents Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Dopamine Agents Sales Market Share by Application (2015-2020)
Table 69. Glaxosmithkline Corporation Information
Table 70. Glaxosmithkline Description and Major Businesses
Table 71. Glaxosmithkline Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Glaxosmithkline Product
Table 73. Glaxosmithkline Recent Development
Table 74. Actavis Corporation Information
Table 75. Actavis Description and Major Businesses
Table 76. Actavis Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 77. Actavis Product
Table 78. Actavis Recent Development
Table 79. Eli Lilly Corporation Information
Table 80. Eli Lilly Description and Major Businesses
Table 81. Eli Lilly Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 82. Eli Lilly Product
Table 83. Eli Lilly Recent Development
Table 84. Sun Pharmaceutical Corporation Information
Table 85. Sun Pharmaceutical Description and Major Businesses
Table 86. Sun Pharmaceutical Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 87. Sun Pharmaceutical Product
Table 88. Sun Pharmaceutical Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Merck Corporation Information
Table 95. Merck Description and Major Businesses
Table 96. Merck Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 97. Merck Product
Table 98. Merck Recent Development
Table 99. Cardinal Health Corporation Information
Table 100. Cardinal Health Description and Major Businesses
Table 101. Cardinal Health Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 102. Cardinal Health Product
Table 103. Cardinal Health Recent Development
Table 104. Pfizer Corporation Information
Table 105. Pfizer Description and Major Businesses
Table 106. Pfizer Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 107. Pfizer Product
Table 108. Pfizer Recent Development
Table 109. Teva Corporation Information
Table 110. Teva Description and Major Businesses
Table 111. Teva Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 112. Teva Product
Table 113. Teva Recent Development
Table 114. Abbott Corporation Information
Table 115. Abbott Description and Major Businesses
Table 116. Abbott Dopamine Agents Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 117. Abbott Product
Table 118. Abbott Recent Development
Table 119. Global Dopamine Agents Sales Forecast by Regions (2021-2026) (Kiloton)
Table 120. Global Dopamine Agents Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Dopamine Agents Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Dopamine Agents Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Dopamine Agents Sales Forecast by Country (2021-2026) (Kiloton)
Table 124. North America: Dopamine Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Dopamine Agents Sales Forecast by Country (2021-2026) (Kiloton)
Table 126. Europe: Dopamine Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Dopamine Agents Sales Forecast by Region (2021-2026) (Kiloton)
Table 128. Asia Pacific: Dopamine Agents Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Dopamine Agents Sales Forecast by Country (2021-2026) (Kiloton)
Table 130. Latin America: Dopamine Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Dopamine Agents Sales Forecast by Country (2021-2026) (Kiloton)
Table 132. Middle East and Africa: Dopamine Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Dopamine Agents Players
Table 137. Dopamine Agents Customers List
Table 138. Dopamine Agents Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Dopamine Agents Product Picture
Figure 2. Global Dopamine Agents Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injectable Product Picture
Figure 5. Global Dopamine Agents Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Dopamine Agents Report Years Considered
Figure 9. Global Dopamine Agents Market Size 2015-2026 (US$ Million)
Figure 10. Global Dopamine Agents Sales 2015-2026 (Kiloton)
Figure 11. Global Dopamine Agents Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Dopamine Agents Sales Market Share by Region (2015-2020)
Figure 13. Global Dopamine Agents Sales Market Share by Region in 2019
Figure 14. Global Dopamine Agents Revenue Market Share by Region (2015-2020)
Figure 15. Global Dopamine Agents Revenue Market Share by Region in 2019
Figure 16. Global Dopamine Agents Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Dopamine Agents Revenue in 2019
Figure 18. Dopamine Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Dopamine Agents Sales Market Share by Type (2015-2020)
Figure 20. Global Dopamine Agents Sales Market Share by Type in 2019
Figure 21. Global Dopamine Agents Revenue Market Share by Type (2015-2020)
Figure 22. Global Dopamine Agents Revenue Market Share by Type in 2019
Figure 23. Global Dopamine Agents Market Share by Price Range (2015-2020)
Figure 24. Global Dopamine Agents Sales Market Share by Application (2015-2020)
Figure 25. Global Dopamine Agents Sales Market Share by Application in 2019
Figure 26. Global Dopamine Agents Revenue Market Share by Application (2015-2020)
Figure 27. Global Dopamine Agents Revenue Market Share by Application in 2019
Figure 28. North America Dopamine Agents Sales Growth Rate 2015-2020 (Kiloton)
Figure 29. North America Dopamine Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Dopamine Agents Sales Market Share by Country in 2019
Figure 31. North America Dopamine Agents Revenue Market Share by Country in 2019
Figure 32. U.S. Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 33. U.S. Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 35. Canada Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Dopamine Agents Market Share by Type in 2019
Figure 37. North America Dopamine Agents Market Share by Application in 2019
Figure 38. Europe Dopamine Agents Sales Growth Rate 2015-2020 (Kiloton)
Figure 39. Europe Dopamine Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Dopamine Agents Sales Market Share by Country in 2019
Figure 41. Europe Dopamine Agents Revenue Market Share by Country in 2019
Figure 42. Germany Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 43. Germany Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 45. France Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 47. U.K. Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 49. Italy Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 51. Russia Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Dopamine Agents Market Share by Type in 2019
Figure 53. Europe Dopamine Agents Market Share by Application in 2019
Figure 54. Asia Pacific Dopamine Agents Sales Growth Rate 2015-2020 (Kiloton)
Figure 55. Asia Pacific Dopamine Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Dopamine Agents Sales Market Share by Region in 2019
Figure 57. Asia Pacific Dopamine Agents Revenue Market Share by Region in 2019
Figure 58. China Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 59. China Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 61. Japan Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 63. South Korea Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 65. India Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 67. Australia Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 69. Taiwan Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 71. Indonesia Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 73. Thailand Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 75. Malaysia Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 77. Philippines Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 79. Vietnam Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Dopamine Agents Market Share by Type in 2019
Figure 81. Asia Pacific Dopamine Agents Market Share by Application in 2019
Figure 82. Latin America Dopamine Agents Sales Growth Rate 2015-2020 (Kiloton)
Figure 83. Latin America Dopamine Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Dopamine Agents Sales Market Share by Country in 2019
Figure 85. Latin America Dopamine Agents Revenue Market Share by Country in 2019
Figure 86. Mexico Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 87. Mexico Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 89. Brazil Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 91. Argentina Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Dopamine Agents Market Share by Type in 2019
Figure 93. Latin America Dopamine Agents Market Share by Application in 2019
Figure 94. Middle East and Africa Dopamine Agents Sales Growth Rate 2015-2020 (Kiloton)
Figure 95. Middle East and Africa Dopamine Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Dopamine Agents Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Dopamine Agents Revenue Market Share by Country in 2019
Figure 98. Turkey Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 99. Turkey Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 101. Saudi Arabia Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Dopamine Agents Sales Growth Rate (2015-2020) (Kiloton)
Figure 103. UAE Dopamine Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Dopamine Agents Market Share by Type in 2019
Figure 105. Middle East and Africa Dopamine Agents Market Share by Application in 2019
Figure 106. North America Dopamine Agents Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 107. North America Dopamine Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Dopamine Agents Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 109. Europe Dopamine Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Dopamine Agents Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 111. Asia Pacific Dopamine Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Dopamine Agents Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 113. Latin America Dopamine Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Dopamine Agents Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 115. Middle East and Africa Dopamine Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
マイクロバブル/超音波造影剤の世界市場（～2026年） Microbubbles/ultrasound contrast agents are small spherical bubbles comprised of three phases, namely innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound; thereby used for ultrasound imaging a…- 骨密度維持薬の世界市場（～2026年） Market Analysis and Insights: Global Bone Density Conservation Agents Market The global Bone Density Conservation Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Bone Density Conservation Agents Scope and Market…
- 固結防止剤の世界市場（～2026年） Anti-caking agents are utilized to prevent the formation of lumps, mostly in finely powdered substances. Anti-caking agents are soluble in alcohol, water and other organic solvents. They either absorb excess moisture or create a water-repellent coating on the powdered particles. Asia Pacific is expe…
- 分子イメージング剤の世界市場（～2026年） Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratificati…
- MRI造影剤の世界市場（～2026年） MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues …